|
|
 Pharmaceutical Information - November 20, 2008
| A new study reveals 8 out of 10 African Americans are unaware of the importance of speaking to their loved ones about their wish to become a donor. In response to the study, The Links, Incorporated and Roche pharmaceutical company will distribute thousands of conversation starter guides at organ donor awareness church events nationwide on National Donor Sabbath, November 13 | | After a morning of frightening scenario's played out by President Bush regarding the possibility of an avian flu pandemic, pharmaceutical giant Roche says it is prepared to tackle the virus along with the U.S. Government. Roche announces it is prepared to supply its antiviral medication Tamiflu for the Strategic National Stockpile, following President Bush's remarks at the National Institutes of Health Tuesday | | China's largest drug maker, Shanghai Pharmaceutical Group, begins talks with Tamiflu maker Roche about making the antiviral drug, thought to be the best defense against a possible flu pandemic. Roche Holding AG's spokesperson in Shanghai, Xu Chao, says Shanghai Pharmaceutical has been in touch about producing Tamiflu | | Shire Pharmaceuticals Inc. presents new data demonstrating that the drug Adderall XR significantly improves symptoms in adults with Attention-Deficit/Hyperactivity Disorder (ADHD). Nearly 75-percent of study participants experienced improvement in ADHD symptoms, according to preliminary results of the Quality of Life, Effectiveness, Safety, and Tolerability (Qu.E.S.T.) study, presented at the annual meeting of Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) | | Shire Pharmaceuticals Inc. unveils new data demonstrating highly prescribed children' drug Adderall significantly improves symptoms in adults with attention deficit-hyperactivity disorder (ADHD). Nearly 75-percent of study participants experienced improvement in ADHD symptoms, according to preliminary results of the Quality of Life, Effectiveness, Safety, and Tolerability (Qu.E.S.T.) study, presented the data at the annual meeting of Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) | |
|
|